130 related articles for article (PubMed ID: 31274636)
1. Incidental Detection of a Radiation-Induced Soft-Tissue Sarcoma on 68Ga-PSMA PET/CT in a Patient Previously Treated for Prostate Cancer.
Plouznikoff N; Woff E; Artigas C; Alexiou J; Flamen P
Clin Nucl Med; 2019 Aug; 44(8):e501-e502. PubMed ID: 31274636
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Incidental Detection of Pleomorphic Sarcoma on 68Ga-PSMA PET/CT in a Patient With Prostate Cancer.
Mathew B; Agrawal A; Purandare NC; Ramadwar M; Menon S; Bakshi G; Joshi A; Puranik A; Shah S; Rangarajan V
Clin Nucl Med; 2020 Feb; 45(2):e120-e121. PubMed ID: 31490315
[TBL] [Abstract][Full Text] [Related]
4. Incidental Detection of Hypothyroidism on 68Ga-PSMA-HBED-CC PET/CT Imaging.
Sood A; Vadi SK; Kumar R; Singh H; Mittal BR
Clin Nucl Med; 2020 Apr; 45(4):e217-e218. PubMed ID: 32108699
[TBL] [Abstract][Full Text] [Related]
5. Detection Efficacy of Hybrid
Einspieler I; Rauscher I; Düwel C; Krönke M; Rischpler C; Habl G; Dewes S; Ott A; Wester HJ; Schwaiger M; Maurer T; Eiber M
J Nucl Med; 2017 Jul; 58(7):1081-1087. PubMed ID: 28209912
[TBL] [Abstract][Full Text] [Related]
6. 68Ga-PSMA-Avid Small Cell Lung Cancer on PET/CT: Incidental Second Malignancy in Treated Prostate Cancer.
Sharma P
Clin Nucl Med; 2020 Dec; 45(12):1016-1017. PubMed ID: 32956110
[TBL] [Abstract][Full Text] [Related]
7. Impact of
Schmidt-Hegemann NS; Eze C; Li M; Rogowski P; Schaefer C; Stief C; Buchner A; Zamboglou C; Fendler WP; Ganswindt U; Cyran C; Bartenstein P; Belka C; Ilhan H
J Nucl Med; 2019 Jul; 60(7):963-970. PubMed ID: 30552203
[No Abstract] [Full Text] [Related]
8. Intention-to-Treat Analysis of
Schwenck J; Olthof SC; Pfannenberg C; Reischl G; Wegener D; Marzec J; Bedke J; Stenzl A; Nikolaou K; la Fougère C; Zips D; Müller AC
J Nucl Med; 2019 Oct; 60(10):1359-1365. PubMed ID: 30850491
[TBL] [Abstract][Full Text] [Related]
9.
Hamed MAG; Basha MAA; Ahmed H; Obaya AA; Afifi AHM; Abdelbary EH
Acad Radiol; 2019 Apr; 26(4):450-460. PubMed ID: 29935970
[TBL] [Abstract][Full Text] [Related]
10. Low 68Ga-PSMA PET/CT Uptake in Chronic Intramuscular Nodular Fasciitis.
Plouznikoff N; Artigas C; Karfis I; Flamen P
Clin Nucl Med; 2020 Jan; 45(1):e41-e42. PubMed ID: 31246686
[TBL] [Abstract][Full Text] [Related]
11. The impact of [
Frenzel T; Tienken M; Abel M; Berliner C; Klutmann S; Beyersdorff D; Schwarz R; Krüll A; Bannas P
Strahlenther Onkol; 2018 Jul; 194(7):646-654. PubMed ID: 29572670
[TBL] [Abstract][Full Text] [Related]
12. 68Ga-labeled PSMA-11 (68Ga-isoPROtrace-11) synthesized with ready to use kit: normal biodistribution and uptake characteristics of tumour lesions.
Kurash MM; Gill R; Khairulin M; Harbosh H; Keidar Z
Sci Rep; 2020 Feb; 10(1):3109. PubMed ID: 32080309
[TBL] [Abstract][Full Text] [Related]
13. Distribution of prostate cancer recurrences on gallium-68 prostate-specific membrane antigen (
Huits TH; Luiting HB; van der Poel HG; Nandurkar R; Donswijk M; Schaake E; Vogel W; Roobol MJ; Wit E; Stricker P; Emmett L; van Leeuwen PJ
BJU Int; 2020 Jun; 125(6):876-883. PubMed ID: 32181951
[TBL] [Abstract][Full Text] [Related]
14. Potential Causes of False-Negative Interpretations in 68Ga-PSMA PET/CT for the Detection of Local and Recurrent Prostate Cancer: An Underexposed Issue.
Yakar D; Noordzij W; Kwee TC
Clin Nucl Med; 2020 Jan; 45(1):e32-e35. PubMed ID: 31348089
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of 68Ga-PSMA PET/CT Uptake in Fibrous Dysplasia.
Plouznikoff N; Garcia C; Artigas C; Entezari K; Flamen P
Clin Nucl Med; 2019 Oct; 44(10):e593-e594. PubMed ID: 31058693
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic performance of
Zhang J; Shao S; Wu P; Liu D; Yang B; Han D; Li Y; Lin X; Song W; Cao M; Zhang J; Kang F; Qin W; Wang J
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):908-920. PubMed ID: 30635755
[TBL] [Abstract][Full Text] [Related]
17. Importance of
Couñago F; Artigas C; Sancho G; Gómez-Iturriaga A; Gómez-Caamaño A; Maldonado A; Caballero B; López-Campos F; Recio M; Del Cerro E; Henríquez I
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(5):302-314. PubMed ID: 30139594
[TBL] [Abstract][Full Text] [Related]
18.
Basha MAA; Hamed MAG; Hussein O; El-Diasty T; Abdelkhalek YI; Hussein YO; Alasamer AF; Mohamed HAE; Deen DSE; Tantawy EF; Metwally MI; Zaitoun MMA; Aly SA; Altohamy JI; Mohamed AEM; Afifi AHM; Harb O
Abdom Radiol (NY); 2019 Jul; 44(7):2545-2556. PubMed ID: 30963182
[TBL] [Abstract][Full Text] [Related]
19. MRI versus ⁶⁸Ga-PSMA PET/CT for gross tumour volume delineation in radiation treatment planning of primary prostate cancer.
Zamboglou C; Wieser G; Hennies S; Rempel I; Kirste S; Soschynski M; Rischke HC; Fechter T; Jilg CA; Langer M; Meyer PT; Bock M; Grosu AL
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):889-897. PubMed ID: 26592938
[TBL] [Abstract][Full Text] [Related]
20.
von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G
Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
